Clinical trial
PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin (…
NCT00077805 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00077805 |
|---|---|
| Title | PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin) |
| Official title | An Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin in the Prevention of Venous Thromboembolism in Patients Following Acute Ischemic Stroke |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acute Ischemic Stroke |
| Intervention type | Drug |
| Interventions | Enoxaparin sodium |
| Start date | Aug 1, 2003 |
| Primary completion | Jul 1, 2006 |
| First posted | Feb 16, 2004 |
| Last update posted | Jan 11, 2011 |
| Countries | Australia, Austria, Brazil, Canada, Colombia, Czechia, India, Israel, Italy, Mexico, Poland, South Africa and 3 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: